This site uses third parties to own and optimize your navigation and perform analytical work cookies. If you continue browsing, consider that you accept its use.
You can learn more at our Cookie Policy.


  • Innoprot
    • Productos
      • GPCR Cell Lines
        • DAG-NOMAD GPCR Cell Lines


Reference: P70609

Get your Price

Data Sheet

A novel ADRA1B Nomad cell line has been developed stably transfecting DAG Nomad biosensor and Alpha-1B adrenergic receptor into U2OS cell line.

Innoprot DAG-Nomad ADRA1B cell line has been designed to assay compounds or analyze their capability to modulate Alpha-1B adrenergic receptor. When the agonist binds to ADRA1B a G protein is activated, which in turn, triggers a cellular response mediated by second messengers (DAG).

Assay Details

In absence of DAG, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of DAG-Nomad Biosensor that promotes its cellular relocation in the vesicular trafficking of the cells and a fluorescence intensity increase. Activity is easily quantified on living cells by fluorescence intensity using any microplate reader.

This highly reproducible assay has been validated using Epinephrine as a ADRA1B agonist in both fluorescent intensity and Image analysis platforms. This cell line has been validated measuring DAG increase in the cytosol analyzing Nomad biosensor distribution and fluorescence increase, showing averages higher than of Z´= 0.80+/- 0.01.

Materials Provided

  • P70609: 2 vials of 3 million stably transfected U2OS Cells expressing ADRA1B and DAG-Nomad Biosensor 

Related Products/Services

© Innoprot 2008 - Cell Based Assays for Drug Discovery Screening - Cookie Policy